amsacrine has been researched along with Abnormal Karyotype in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Abnormal Karyotype: A variation from the normal set of chromosomes characteristic of a species.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmid, C | 1 |
Schleuning, M | 1 |
Tischer, J | 1 |
Holler, E | 1 |
Haude, KH | 1 |
Braess, J | 1 |
Haferlach, C | 1 |
Baurmann, H | 1 |
Oruzio, D | 1 |
Hahn, J | 1 |
Spiekermann, K | 1 |
Schlimok, G | 1 |
Schwerdtfeger, R | 1 |
Buechner, T | 1 |
Hiddemann, W | 1 |
Kolb, HJ | 1 |
1 trial available for amsacrine and Abnormal Karyotype
Article | Year |
---|---|
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Topics: Abnormal Karyotype; Acute Disease; Adolescent; Adult; Amsacrine; Antilymphocyte Serum; Antineoplasti | 2012 |